Gabriel N. Hortobagyi

Statistics

Publications

Citations

2.1K

H-Index

Active since

1987

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Breast Cancer Care

Gabriel N. Hortobagyi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, breast cancer, and radiation oncology.

Top concepts

MedicineBreast CancerRadiation OncologyOncologyCancer ResearchCell BiologyPathologyTumor BiologyCancer BiologyCancer Therapy

Publications per year

1987–2014

Publications

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

Allan Lipton, Richard L. Theriault, Gabriel N. Hortobagyi et al. · Cancer · 2000 · 672 citations

Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma

Gabriel N. Hortobagyi, Aman U. Buzdar, Richard L. Theriault et al. · JNCI Journal of the National Cancer Institute · 2000 · 169 citations

Clinical course of breast cancer patients with liver metastases.

Juan W Zinser, Gabriel N. Hortobagyi, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1987 · 166 citations

Surgical Oncology, Breast Oncology, June 1973 +17

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.

Zillur Rahman, D. Frye, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1997 · 155 citations

Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.

Lianglin Zhang, Y.K. James Lau, Weiya Xia et al. · PubMed · 1999 · 151 citations

Tyrosine Kinase Inhibitor, Tumor Biology, Breast Oncology +14

1–5 of 18